Trials
Search / Trial NCT06425250

Campylobacter Spp. Bone and Joint Infection: a Retrospective Cohort Study

Launched by HOSPICES CIVILS DE LYON · May 17, 2024

Apply for Trial

Trial Information

Current as of March 12, 2025

Recruiting

Keywords

Management Risk Factors Campylobacter Spp.

ClinConnect Summary

This clinical trial is looking into infections caused by Campylobacter bacteria, which are usually known for causing digestive issues but can also lead to serious bone and joint infections. Researchers want to understand how these infections occur and how best to treat them, as there isn’t a standard approach currently available. The study is focused on patients who have been diagnosed with various types of bone and joint infections linked to Campylobacter between January 2013 and December 2022.

To participate in this study, you need to be at least 18 years old and have a confirmed Campylobacter-related bone or joint infection, such as septic arthritis or osteomyelitis. If you join, you can expect to share your medical history and may undergo tests to confirm your infection. This research is important because it aims to improve the understanding and treatment of these infections, which can be difficult to manage due to the bacteria's ability to resist some antibiotics. The study is currently recruiting participants of all genders.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • \> 18 years
  • * Osteoarticular infection (whatever its type), mono or polymicrobial with Campylobacter spp., diagnosed between 01/01/2013 and 12/31/2022:
  • • Septic arthritis: compatible clinical signs + joint fluid sample positive in culture and/or PCR positive for Campylobacter
  • • Spondylodiscitis: clinical signs and MRI compatible + blood cultures and/or disco-vertebral biopsy puncture positive in culture and/or PCR positive for Campylobacter
  • • Osteitis/osteomyelitis: compatible clinico-radiological picture + bone sample (biopsy or intraoperative sample) positive in culture and/or positive PCR for Campylobacter
  • • Infection on joint prosthesis or osteosynthesis equipment: documented Campylobacter infection and meeting the definition of probable or confirmed JIBS infections
  • • Patient who was informed and did not object to participating in the study
  • Exclusion Criteria:
  • • -

About Hospices Civils De Lyon

Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.

Locations

Lyon, , France

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0